254 related articles for article (PubMed ID: 23039377)
1. Ipsilateral adrenalectomy at the time of radical nephrectomy impacts overall survival.
Yap SA; Alibhai SM; Abouassaly R; Timilshina N; Margel D; Finelli A
BJU Int; 2013 Mar; 111(3 Pt B):E54-8. PubMed ID: 23039377
[TBL] [Abstract][Full Text] [Related]
2. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
[TBL] [Abstract][Full Text] [Related]
3. Reconsidering the necessity of ipsilateral adrenalectomy during radical nephrectomy for renal cell carcinoma.
Leibovitch I; Raviv G; Mor Y; Nativ O; Goldwasser B
Urology; 1995 Sep; 46(3):316-20. PubMed ID: 7660505
[TBL] [Abstract][Full Text] [Related]
4. Investigation on the indication of ipsilateral adrenalectomy in radical nephrectomy: a meta-analysis.
Su JR; Zhu DJ; Liang W; Xie WL
Chin Med J (Engl); 2012 Nov; 125(21):3885-90. PubMed ID: 23106893
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
6. Do we continue to unnecessarily perform ipsilateral adrenalectomy at the time of radical nephrectomy? A population based study.
Yap SA; Alibhai SM; Abouassaly R; Timilshina N; Finelli A
J Urol; 2012 Feb; 187(2):398-404. PubMed ID: 22177155
[TBL] [Abstract][Full Text] [Related]
7. Adrenal sparing surgery during radical nephrectomy in patients with renal cell cancer: a new algorithm.
Paul R; Mordhorst J; Busch R; Leyh H; Hartung R
J Urol; 2001 Jul; 166(1):59-62. PubMed ID: 11435823
[TBL] [Abstract][Full Text] [Related]
8. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
9. Real indications for adrenalectomy in renal cell carcinoma.
Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous adrenalectomy during radical nephrectomy for renal cell carcinoma will not cure patients with adrenal metastasis.
von Knobloch R; Schrader AJ; Walthers EM; Hofmann R
Urology; 2009 Feb; 73(2):333-6. PubMed ID: 19038420
[TBL] [Abstract][Full Text] [Related]
11. Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy?
Yokoyama H; Tanaka M
BJU Int; 2005 Mar; 95(4):526-9. PubMed ID: 15705073
[TBL] [Abstract][Full Text] [Related]
12. Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system.
Alamdari FI; Ljungberg B
Scand J Urol Nephrol; 2005; 39(4):277-82. PubMed ID: 16118103
[TBL] [Abstract][Full Text] [Related]
13. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
Krambeck A; Iwaszko M; Leibovich B; Cheville J; Frank I; Blute M
BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
[TBL] [Abstract][Full Text] [Related]
15. Adrenal sparing surgery for renal cell carcinoma.
Xu C; Niu Z; Lü J; Wang J
Chin Med J (Engl); 1998 Oct; 111(10):877-80. PubMed ID: 11189230
[TBL] [Abstract][Full Text] [Related]
16. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
[TBL] [Abstract][Full Text] [Related]
18. Management of the adrenal gland during partial nephrectomy.
Lane BR; Tiong HY; Campbell SC; Fergany AF; Weight CJ; Larson BT; Novick AC; Flechner SM
J Urol; 2009 Jun; 181(6):2430-6; discussion 2436-7. PubMed ID: 19371896
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
Kuczyk M; Wegener G; Jonas U
Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of tumour multifocality in renal cell carcinoma.
Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
